Yahoo
NasdaqCM - Delayed Quote USD

Creative Medical Technology Holdings, Inc. (CELZ)

1.3100 +0.0300 (+2.34%)
At close: August 21 at 4:00:01 PM EDT
1.3300 +0.0200 (+1.53%)
After hours: August 21 at 7:51:12 PM EDT
Chart Range Bar
Loading chart for CELZ
  • Previous Close 1.2800
  • Open 1.2700
  • Bid 0.9576 x 200
  • Ask 1.5700 x 200
  • Day's Range 1.2200 - 1.3500
  • 52 Week Range 0.6200 - 6.2500
  • Volume 543,387
  • Avg. Volume 9,803,588
  • Market Cap (intraday) 8.636M
  • Beta (5Y Monthly) 1.94
  • PE Ratio (TTM) --
  • EPS (TTM) -2.0800
  • Earnings Date (est.) --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 20.00

Creative Medical Technology Holdings, Inc., a commercial-stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction, and FemCelz for the treatment of loss of genital sensitivity and dryness. It develops AlloStem (CELZ-201-DDT), a allogenic human perinatal tissue derived cell program, ImmCelz (CELZ-100), a personalized supercharged immune therapy platform; CELZ-201 CREATE-1, which is phase 2, for the treatment of type 1 diabetes; AlloStemSpine (CELZ 201 ADAPT), which is phase 2, for the treatment of chronic lower back pain; Alova, a platform to treat infertility as a result of premature ovarian failure; StemSpine, a regenerative stem cell procedure to treat degenerative disc disease; OvaStem, a stem cell therapy for premature ovarian failure; CaverStem for erectile dysfunction treatment; and FemCelz for female sexual function treatment. In addition, the company develops products and services for various indications, including preventing the rejection of transplanted organs, kidney failure, liver failure, heart attack, and Parkinson's disease. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.

www.creativemedicaltechnology.com

4

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 8/21/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

CELZ
33.16%
S&P 500 (^GSPC)
12.11%

1-Year Return

CELZ
58.54%
S&P 500 (^GSPC)
20.47%

3-Year Return

CELZ
72.30%
S&P 500 (^GSPC)
74.43%

5-Year Return

CELZ
99.01%
S&P 500 (^GSPC)
72.78%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q1 FY26
Revenue --
Earnings -1.41M
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q1

FY26

-2M
-1M
-500K
0
-60000.0%
-40000.0%
-20000.0%
0.0%

Analyst Insights

View More

Analyst Price Targets

20.00
20.00 Average
1.3100 Current
20.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
As of 8/20/2026
  • Market Cap

    8.50M

  • Enterprise Value

    -334.72k

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.33k

  • Price/Book (mrq)

    0.98

  • Enterprise Value/Revenue

    753.53

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -47.32%

  • Return on Equity (ttm)

    -77.88%

  • Revenue (ttm)

    3k

  • Net Income Avi to Common (ttm)

    -6.04M

  • Diluted EPS (ttm)

    -2.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.84M

  • Total Debt/Equity (mrq)

    0.16%

  • Levered Free Cash Flow (ttm)

    -3.46M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

1.3100 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: